Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The inherited bone marrow failure (BMF) syndromes are a rare and diverse group of genetic disorders that ultimately result in the loss of blood production. The molecular defects underlying many of these conditions have been elucidated, and great progress has been made toward understanding the normal function of these gene products. This review will focus on perhaps the most well-known and genetically heterogeneous BMF syndrome: Fanconi anemia. More specifically, this account will review the current state of our knowledge on why the bone marrow fails in this illness and what this might tell us about the maintenance of bone marrow function and hematopoiesis.

Original publication

DOI

10.1182/blood-2013-09-427740

Type

Journal article

Journal

Blood

Publication Date

02/01/2014

Volume

123

Pages

26 - 34

Keywords

Animals, Bone Marrow, Bone Marrow Diseases, Bone Marrow Transplantation, Cross-Linking Reagents, DNA Damage, DNA Repair, Fanconi Anemia, Fanconi Anemia Complementation Group Proteins, Humans, Mice, Stem Cells